The Christie NHS Foundation Trust

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

• The Christie NHS Foundation Trust

  Manchester, M20 4BX

  242 vizsgálat

• The Christie NHS Foundation Trust - Christie Hospital

  Manchester, Greater Manchester M204BX

  17 vizsgálat

• Christie Hospital NHS Foundation Trust

  Manchester, M20 4BX

  8 vizsgálat

• Christie NHS Foundation Trust

  Manchester, M20 4BX

  8 vizsgálat

• The Christie Hospital NHS Foundation Trust

  Manchester, M20 4BX

  5 vizsgálat

• The Christie Hospital, The Christie NHS Foundation Trust

  Manchester, M20 4BX

  4 vizsgálat

• The Christie NHS Foundation Trust

  Withington, Greater Manchester M20 1BX

  3 vizsgálat

  • NCT07096778Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

    Contact: CCS1477-04 Clinical Operations

  • NCT07202260Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung

  • NCT04778397Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

• The Christie Nhs Foundation Trust

  Manchester Greater, M204BX

  2 vizsgálat

  • NCT07214779Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • NCT07023627A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

• The Christie NHS Foundation Trust, Department of Medical Oncology

  Manchester, M20 4BX

  2 vizsgálat

  • NCT05502237Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

  • NCT04104776A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

    Contact: Novartis Pharmaceuticals

• The Christie NHS Foundation Trust - Medical Oncology

  Manchester, M20 4BX

  2 vizsgálat

  • NCT04907851A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

  • NCT04987203Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

• The Christie NHS Foundation Trust - PPDS

  Manchester, M20 4GJ

  2 vizsgálat

  • NCT04129502TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

  • NCT01909453Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

• Cancer Research UK - Christie Hospital Foundation NHS Trust - Dept of Medical Oncology

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04083235A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

• Christie NHS Foundation Trust

  GB Manchester, M20 4BX

  1 vizsgálat

  • NCT05091567A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

• Christie NHS Foundation Trust (Site 0275)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT03829319Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

• Christie NHS Foundation Trust (Site 0604)

  Manchester, M20 4GJ

  1 vizsgálat

  • NCT03553836Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

• Christie NHS Foundation Trust (Site 0805)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT03797326Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

• Christie NHS Foundation Trust (Site 1409)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04380636Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

• Christie NHS Foundation Trust (Site 2903)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04199104A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)

• Department of Medical Oncology, The Christie NHS Foundation Trust

  Manchester, M20 4BX

  1 vizsgálat

  • NCT02684006A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

• The Christie Hospital NHS Foundation Trust (Site 1503)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT03615326Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

• The Christie Hospital NHS Foundation Trust (Site 2243)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04634877Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

• The Christie Nhs Foundation Foundation Trust

  Manchester, M20 4BX

  1 vizsgálat

  • NCT06162572Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

• The Christie NHS Foundation Trust

  Lancaster

  1 vizsgálat

  • NCT06486883Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype

    Contact: MEDSIR

• The Christie NHS Foundation Trust - 2802

  Manchester, London M20 4BX

  1 vizsgálat

  • NCT05671510ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

• The Christie NHS Foundation Trust - Cancer Research Centre

  Manchester, M20 4BX

  1 vizsgálat

  • NCT05533697Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

    Contact: Moderna WeCare Team

• The Christie NHS Foundation Trust - Christie Hospital /ID# 271561

  Manchester, M20 4BX

  1 vizsgálat

  • NCT06820463A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

• The Christie NHS Foundation Trust - Christie Hospital /ID# 276276

  Manchester, M20 4BX

  1 vizsgálat

  • NCT06953960A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

• The Christie NHS Foundation Trust - Christie Hospital /ID# 277304

  Manchester, M20 4BX

  1 vizsgálat

  • NCT07155187A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

• The Christie NHS Foundation Trust (PTC)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04307576A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

    Contact: Anna Castleton, M.D. (principal investigator)

• The Christie NHS Foundation Trust (Site 0282)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04210115Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

• The Christie NHS Foundation Trust (Site 0397)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)

• The Christie NHS Foundation Trust (Site 0405)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT06843447A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 0537)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04003636Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

• The Christie NHS Foundation Trust (Site 0575)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT03713593Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

• The Christie NHS Foundation Trust (Site 0603)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT06504394A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)

• The Christie NHS Foundation Trust (Site 0907)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT04428151Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

• The Christie NHS Foundation Trust (Site 1001)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT06307431A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

• The Christie NHS Foundation Trust (Site 1300)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT07519772A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 1306)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT06305767A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

• The Christie NHS Foundation Trust (Site 1400)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04626479Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)

• The Christie NHS Foundation Trust (Site 1401)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04195750A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

• The Christie NHS Foundation Trust (Site 1436)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT06136650A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 1602)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT03142334Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

• The Christie NHS Foundation Trust (Site 1608)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 1755)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT06997497A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 1814)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT05933577A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

• The Christie NHS Foundation Trust (Site 1909)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04949256Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

• The Christie NHS Foundation Trust (Site 2066)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT06623422A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 2208)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT07060807A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 2209)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04662710Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

• The Christie NHS Foundation Trust (Site 2405)

  Manchester, M20 4GJ

  1 vizsgálat

  • NCT04624204Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

• The Christie NHS Foundation Trust (Site 2602)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04728893Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 2604)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT06074588Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

• The Christie NHS Foundation Trust (Site 2804)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT07318558A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 3301)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT05239728A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

• The Christie NHS Foundation Trust (Site 3307)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT06079879A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

• The Christie NHS Foundation Trust (Site 3400)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04626518Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)

• The Christie NHS Foundation Trust (Site 3901)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT06780137A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

    Contact: Toll Free Number

• The Christie NHS Foundation Trust (Site 4003)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT06952504A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 5400)

  Manchester, M20 4BX

  1 vizsgálat

  • NCT07049926Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

    Contact: Study Coordinator

• The Christie NHS Foundation Trust (Site 7007)

  Manchester, m20 4bx

  1 vizsgálat

  • NCT05458297A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

• The Christie NHS Foundation Trust - SSC Parent

  Manchester, M20 4BX

  1 vizsgálat

  • NCT05306340A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

• The Christie NHS Foundation trust - The Christie NHS Foundation Trust

  Manchester, M20 4BX

  1 vizsgálat

  • NCT03818503E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

    Contact: EORTC HQ

• The Christie - The Christie NHS Foundation Trust

  Manchester, M20 4BX

  1 vizsgálat

  • NCT04526899A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

• The Research And Development Office, The Christie NHS Foundation Trust

  Manchester, M204BX

  1 vizsgálat

  • NCT01740427A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)